The ECB is facing a critical debate about whether to embark on an American-style quantitative easing program. Here are the implications.» Read More
CNBC's Kate Kelly reports on a trend by hedge funds looking for bullish long-term value stories.
Flemming Ornskov, CEO of Shire Pharmaceutical, says that its latest acquisition, Viropharma, is a "strategic fit" whose main product should become a growth engine.
There is certainly more money going into stock mutual funds this year, but it may not be the tidal wave everyone has been waiting for.
A Reuters study found that Iran's Ayatollah Khamenei controls a massive financial empire built from property seizures from ordinary Iranians.
CNBC's Tyler Mathisen looks ahead to what are likely to be next week's top business and financial stories. Monday is Veterans Day and Kohl's, Macy's and Wal-Mart report earnings.
The judge in the SAC case will wait to decide whether to accept SAC's guilty plea until after a pre-sentencing report is filed.
Bank of America asks federal court to drop two government suits accusing it of defrauding investors during the financial crisis.
RSA Insurance said on Friday it had suspended the top executives of its Irish business while it investigates certain issues.
Wasn't the shutdown supposed to turn the October jobs report into an irrelevant, disposable number?
The official "Squawk Box" blog looks at some deluxe apartments in the sky, the Twitter IPO, and one state's proposal to raise money via weed.
Despite record highs, stocks are "cheap on stock valuations alone," billionaire investor Ron Baron told CNBC Friday.
Raman Bet-Mansour, partner at Debevoise & Plimpton LLP, discusses the recent string of IPOs including Merlin and Twitter.
Gerben Visser, Founder and Managing Partner at IncubAsia Ventures, describes the kind of companies venture capitalists are interested in following the frenzied trade in Twitter shares.
New York Fed President Williams Dudley said he's not sure breaking up large banks is the best way to prevent a crisis in the U.S. financial system.
Eminence Capital has taken a 9.8 percent stake in the clothier and will argue to solicit more bids, CNBC's David Faber reported.
The SEC alleged that RBS misled investors in a financial crisis-era subprime mortgage product.
Lawyers for SAC portfolio manager Michael Steinberg have asked a judge to weed out prospective jurors with views on the firm's settlement agreement.
NYPD has denied that its commissioner, Ray Kelly, was in talks with JPMorgan Chase about a senior role in security at the bank.
Twitter has finally priced. Everyone is worried about a technology glitch, but my concern is that this could be a moonshot open.
Toll Brothers is buying the home building unit of Shapell Industries for about $1.6 billion, strengthening its position in California.
Get the best of CNBC in your inbox
All those headlines about new stock market highs may look sexy, but life for active managers hasn't been quite so much fun.
Investing with top performing managers is probably a bad idea, according to a study of long-term hedge fund performance.
A program to change the way small-company stocks are traded has drawn worry that the initial steps are too tepid.